Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC has a Cash Ratio of 1.09. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
MIC:GEMA's Cash Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.58 * Ranked among companies with meaningful Cash Ratio only.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Cash Ratio Related Terms
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Cash Ratio Chart
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Cash Ratio vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a Cash Ratio of 1.09 as of Dec. 2023. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Cash Ratio too high?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current Cash Ratio is 1.09. The Healthcare Providers & Services industry median Cash Ratio is 0.58. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's value of 1.09 is 87.9% above this industry median. Overall, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Cash Ratio compare to FICO and SPSC?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Cash Ratio of 1.09 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cash Ratio is 0.58. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's value of 1.09 is 87.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.58, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current Cash Ratio of 1.09 is 87.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current Cash Ratio is 1.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC stock overvalued right now?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a current Cash Ratio of 1.09. The current Cash Ratio is 1.09 and 87.9% above the Healthcare Providers & Services industry median of 0.58. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA), the current Cash Ratio is 1.09 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation, and Umbilical Cord tissue, among others.
17GF Score
Get the complete analysis for MIC:GEMA
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIC:GEMA has been successfully added to your 
